Literature DB >> 19498372

IFN-alpha wakes up sleeping hematopoietic stem cells.

Emmanuelle Passegué, Patricia Ernst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19498372      PMCID： PMC2892628          DOI： 10.1038/nm0609-612

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

Review 1.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

2.  Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues.

Authors:  Steffen Massberg; Patrick Schaerli; Irina Knezevic-Maramica; Maria Köllnberger; Noah Tubo; E Ashley Moseman; Ines V Huff; Tobias Junt; Amy J Wagers; Irina B Mazo; Ulrich H von Andrian
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

Review 3.  Dormant and self-renewing hematopoietic stem cells and their niches.

Authors:  Anne Wilson; Gabriela M Oser; Maike Jaworski; William E Blanco-Bose; Elisa Laurenti; Christelle Adolphe; Marieke A Essers; H Robson Macdonald; Andreas Trumpp
Journal:  Ann N Y Acad Sci       Date:  2007-04-18       Impact factor: 5.691

4.  Bedside to bench: interfering with leukemic stem cells.

Authors:  Daniela S Krause; Richard A Van Etten
Journal:  Nat Med       Date:  2008-05       Impact factor: 53.440

5.  CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling.

Authors:  S Hida; K Ogasawara; K Sato; M Abe; H Takayanagi; T Yokochi; T Sato; S Hirose; T Shirai; S Taki; T Taniguchi
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

Review 6.  Punish the parent not the progeny.

Authors:  Lucy J Elrick; Heather G Jorgensen; Joanne C Mountford; Tessa L Holyoake
Journal:  Blood       Date:  2004-11-04       Impact factor: 22.113

Review 7.  Leukemia and hematopoietic stem cells: balancing proliferation and quiescence.

Authors:  Craig D Jude; Justin J Gaudet; Nancy A Speck; Patricia Ernst
Journal:  Cell Cycle       Date:  2008-01-01       Impact factor: 4.534

8.  Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

Authors:  Akinori Takaoka; Sumio Hayakawa; Hideyuki Yanai; Dagmar Stoiber; Hideo Negishi; Hideaki Kikuchi; Shigeru Sasaki; Kohzoh Imai; Tsukasa Shibue; Kenya Honda; Tadatsugu Taniguchi
Journal:  Nature       Date:  2003-07-31       Impact factor: 49.962

9.  Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion.

Authors:  Taku Sato; Nobuyuki Onai; Hiroki Yoshihara; Fumio Arai; Toshio Suda; Toshiaki Ohteki
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

10.  Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate.

Authors:  Giuliana Alimena; Massimo Breccia; Luigia Luciano; Fabrizio Quarantelli; Daniela Diverio; Barbara Izzo; Biagio De Angelis; Marco Mancini; Roberto Latagliata; Ida Carmosino; Mauro Nanni; Marco Picardi; Bruno Rotoli; Franco Mandelli; Fabrizio Pane
Journal:  Leuk Res       Date:  2007-08-10       Impact factor: 3.156
View more
  20 in total

Review 1.  Mechanisms of self-renewal in hematopoietic stem cells.

Authors:  Zhao Wang; Hideo Ema
Journal:  Int J Hematol       Date:  2015-12-12       Impact factor: 2.490

Review 2.  Inflammatory bone marrow microenvironment.

Authors:  Nils B Leimkühler; Rebekka K Schneider
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 3.  Signal transduction pathways, intrinsic regulators, and the control of cell fate choice.

Authors:  Nancy Fossett
Journal:  Biochim Biophys Acta       Date:  2012-06-15

Review 4.  Targeting chronic myeloid leukemia stem cells.

Authors:  G Vignir Helgason; Graham A R Young; Tessa L Holyoake
Journal:  Curr Hematol Malig Rep       Date:  2010-04       Impact factor: 3.952

Review 5.  Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells.

Authors:  Wei Cao; Laura Bover
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

6.  Histone variant H3.3 maintains adult haematopoietic stem cell homeostasis by enforcing chromatin adaptability.

Authors:  Peipei Guo; Ying Liu; Fuqiang Geng; Andrew W Daman; Xiaoyu Liu; Liangwen Zhong; Arjun Ravishankar; Raphael Lis; José Gabriel Barcia Durán; Tomer Itkin; Fanying Tang; Tuo Zhang; Jenny Xiang; Koji Shido; Bi-Sen Ding; Duancheng Wen; Steven Z Josefowicz; Shahin Rafii
Journal:  Nat Cell Biol       Date:  2021-12-27       Impact factor: 28.213

Review 7.  The hematopoietic stem cell niche.

Authors:  Dongsu Park; David B Sykes; David T Scadden
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

8.  Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.

Authors:  Lijing Li; Ludmila Krymskaya; Jianbin Wang; Jill Henley; Anitha Rao; Lan-Feng Cao; Chy-Anh Tran; Monica Torres-Coronado; Agnes Gardner; Nancy Gonzalez; Kenneth Kim; Pei-Qi Liu; Ursula Hofer; Evan Lopez; Philip D Gregory; Qing Liu; Michael C Holmes; Paula M Cannon; John A Zaia; David L DiGiusto
Journal:  Mol Ther       Date:  2013-04-16       Impact factor: 11.454

9.  Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons.

Authors:  Eric M Pietras; Ranjani Lakshminarasimhan; Jose-Marc Techner; Sarah Fong; Johanna Flach; Mikhail Binnewies; Emmanuelle Passegué
Journal:  J Exp Med       Date:  2014-02-03       Impact factor: 14.307

Review 10.  Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output.

Authors:  Maria Fernanda Pascutti; Martje N Erkelens; Martijn A Nolte
Journal:  Front Immunol       Date:  2016-09-16       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.